{"id":"W2166010840","doi":"10.1111/j.1464-410x.2011.10629.x","title":"Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials","year":2011,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Temsirolimus; Pazopanib; Medicine; Sunitinib; Axitinib; Oncology; Internal medicine; Bevacizumab; Sorafenib; Everolimus; Clinical trial; Renal cell carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007481497,0.000612404,0.01852962,0.0004310436,0.00004800204,0.00002916827,0.0005198362,0.0005105699,0.0009053641],"category_scores_gemma":[0.0062077,0.000432154,0.004594081,0.0003265407,0.000121453,0.0001205325,0.0000334444,0.0007519788,0.000004573297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002092011,"about_ca_system_score_gemma":0.00170106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000329237,"about_ca_topic_score_gemma":0.000004676414,"domain_scores_codex":[0.9890037,0.002895046,0.006630465,0.0004505108,0.0005476165,0.0004726176],"domain_scores_gemma":[0.9844978,0.002512944,0.01045663,0.000548996,0.00165999,0.000323676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.004781092,0.0003628899,3.193989e-7,0.8345301,0.003101086,0.0006865117,0.00001789529,3.303212e-7,0.0000307109,0.000002849516,0.004776331,0.1517099],"study_design_scores_gemma":[0.04504662,0.003426869,0.000002598435,0.7789608,0.03158227,0.01385359,0.000003730292,4.990618e-7,0.00007314496,0.00002974184,0.1267187,0.0003014645],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002746227,0.9862934,0.000116668,0.0001199773,0.0006891304,0.01230192,0.0002164886,0.00001328468,0.0002216114],"genre_scores_gemma":[0.00004550549,0.9962612,0.0007156323,0.0004667642,0.0004398114,0.001427221,0.000173474,0.0001200533,0.000350305],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1514085,"threshold_uncertainty_score":0.999813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05609752772833089,"score_gpt":0.3551985738165855,"score_spread":0.2991010460882547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}